We conducted a systematic review and network meta-analysis (NMA) of RCTs to compare the efficacy in achieving target Hb levels and acceptability of different HIF-PHIs and ESAs for treating anemia in CKD patients undergoing dialysis. The gene discussed is GSTM1; the disease is anemia (phenotype).